THC Therapeutics, Inc. reported earnings results for the third quarter and nine months ended April 30, 2023. For the third quarter, the company reported net income was USD 0.094355 million compared to net loss of USD 0.632278 million a year ago.
For the nine months, net loss was USD 0.354095 million compared to USD 1.87 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.06 a year ago.